Tumor size and extent of disease at diagnosis predict the response to initial therapy for papillary thyroid carcinoma in children and adolescents

Patricia A. Powers, Catherine A. Dinauer, R. Michael Tuttle, Daniel K. Robie, Donald R. McClellan, Gary L. Francis

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Treatment of papillary thyroid carcinoma (PTC) in children and adolescents is controversial. We previously showed that large tumor size, multifocal disease, and extensive disease at diagnosis predict recurrence. We examined 47 patients with PTC to determine whether these features predict response to treatment. Overall, 70% of the patients (33/47) remitted with initial treatment. 79% (15/19) of Class I, 86% (12/14) of Class II, and 100% (6/6) of Class III, but none of Class IV patients (n = 8) (p <0.001) achieved remission. Tumor size for patients who entered remission (2.0 ± 0.2 cm) was less than for patients with persistent disease (4.2 ± 0.4) (p <0.0005). Extent of disease at diagnosis correlated with the number of radioactive iodine (RAI) treatments (p = 0.022) and dose (p = 0.002) required to achieve first remission. We conclude that extensive disease at diagnosis and larger tumor size predict failure to remit after initial treatment of PTC in children and adolescents.

Original languageEnglish (US)
Pages (from-to)693-702
Number of pages10
JournalJournal of Pediatric Endocrinology and Metabolism
Volume16
Issue number5
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Keywords

  • Carcinoma
  • Outcome
  • Papillary
  • Pediatrics
  • Recurrence
  • Thyroid

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Tumor size and extent of disease at diagnosis predict the response to initial therapy for papillary thyroid carcinoma in children and adolescents'. Together they form a unique fingerprint.

Cite this